Health Adult Subjects
1
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2025
2026
Energenesis BiomedicalENERGI-F705 Tablets 60 mg
ArjoCLP and pulsation
Clinical Trials (2)
Total enrollment: 44 patients across 2 trials
A Study to Evaluate ENERGI-F705 Tablets in Healthy Volunteers
Start: Feb 2025Est. completion: Nov 202524 patients
Phase 1Completed
A Trial to Investigate the New Caulis Pro® Low Air Loss (LAL) System
Start: Sep 2025Est. completion: Apr 202620 patients
N/ANot Yet Recruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.